Not currently possible.
According to the search, the country has already considered it. It is reported that the company will control the cost to around 100,000, which is very cost-effective. If the next step is to enter medical insurance, according to 60% of the reimbursement limit, the personal burden will be The portions will be smaller, giving more families hope of a cure for cancer.
At the end of 2021, Chongqing Gaojin Biotechnology Co., Ltd. announced the successful development of BPA boron drug, and it is expected to be used in clinical applications in 2023. It claims that this drug can eliminate cancer cells within 30 minutes and is currently mainly used to treat a variety of malignant tumors, including glioma, brain cancer, and melanoma.